ACM
GILD icon

Aster Capital Management’s Gilead Sciences GILD Stock Holding History

Aster Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$849K Buy
7,576
+7,253
+2,246% +$1.02M 0.28% 88
2025
Q4 		$39.6K Sell
323
-1,363
-81% -$166K 0.02% 513
2025
Q3 		$187K Sell
1,686
-623
-27% -$70.8K 0.09% 265
2025
Q2 		$256K Sell
2,309
-13,302
-85% -$1.42M 0.06% 328
2025
Q1 		$1.78M Buy
+15,611
New +$1.61M 0.33% 67
2024
Q4 		– Sell
-10,646
Closed -$893K – 1260
2024
Q3 		$893K Buy
+10,646
New +$812K 0.19% 133

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Aster Capital Management's GILD Position: Q1 2026 in Review

Aster Capital Management increased its Gilead Sciences (GILD) stake by 2,246% in Q1 2026, buying an estimated $1.02M and bringing the position to 7,576 shares worth $849K. The position accounts for 0.28% of the portfolio, ranked #88.

Aster Capital Management first reported a position in GILD in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.78M in Q1 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Aster Capital Management held 7,576 shares of Gilead Sciences worth $849K as of Q1 2026.
  • Aster Capital Management bought 7,253 Gilead Sciences shares in Q1 2026, an estimated $1.02M.
  • Gilead Sciences made up 0.28% of Aster Capital Management's portfolio in Q1 2026, its #88 holding.
  • Aster Capital Management first reported a position in Gilead Sciences in Q3 2024 and has held it in 6 quarters since.
  • Aster Capital Management's Gilead Sciences position peaked at $1.78M in Q1 2025.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.